Why did Lam Research (LRCX) stock move recently?

On 9/1/2026, Lam Research moved -3.7% — Lam Research shares fell as UBS lowered its price target to $425 from $435 (maintaining Buy) and an SEC filing disclosed a pre-arranged insider sale of 5,000 shares by the chief legal officer, amid broader selling pressure on high-multiple tech names and rising yields. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Lam Research (LRCX) overvalued or fairly valued?

MarketChacha shows Lam Research's valuation in context — a trailing P/E of about 61.8, a forward P/E of about 26.4, a price-to-book of about 30.6 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Lam Research's reported profit turn into cash?

Over 4 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.04×) from reported figures — education, not a rating.

What is Lam Research's revenue?

Lam Research reported revenue of $23.2B for FY2026, with net profit of $7.3B, per official filings.

What is the share price of Lam Research (LRCX)?

Lam Research last traded at $307.65 (+5.1% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

Lam Research

LRCX · NASDAQ · Semiconductor Equipment · United States

Snapshot

TickerLRCX

ExchangeNASDAQ

SectorSemiconductor Equipment

IndustrySemiconductor Equipment & Materials

CountryUnited States

Employees23,300

HeadquartersFremont, United States

Websitewww.lamresearch.com

Filings tracked14

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits in the United States, China, Korea, Taiwan, Japan, Southeast Asia, and Europe. The company offers ALTUS systems to deposit conformal or selective films for tungsten or molybdenum metallization applications; SABRE electrochemical deposition products for copper interconnect transition, which support copper damascene manufacturing; Striker single-wafer atomic layer deposition products for dielectric film solutions; and VECTOR plasma-enhanced chemical vapor deposition (CVD) products. It also provides Akara, a conductor etch system designed to enhance etch precision, selectivity, and defect control; Argos, Prevos, and Selis, which are selective etch systems used in the fabrication of advanced logic and memory devices that require precise control at nanoscale dimensions; Flex for dielectric etch applications; Vantex, a dielectric etch system that provides RF technology and repeatable wafer-to-wafer performance enabled by Equipment Intelligence solutions; Kiyo for conductor etch applications; Syndion for deep silicon etch; and Versys metal products for metal etch processes. In addition, the company offers Coronus bevel clean products to enhance die yield and Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications. Further, it provides Reliant deposition, etch, and clean products; Sense.i platform products; and customer service, spares, and upgrades. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.

Who owns it

Insiders0.3%
Institutions88.8%
Public & other10.9%

4,077 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.10.61%
Vanguard Capital Management LLC6.53%
State Street Corporation4.85%
Invesco Ltd.4.18%
JPMORGAN CHASE & CO3.62%
Vanguard Portfolio Management LLC2.93%
Geode Capital Management, LLC2.76%
FMR, LLC2.69%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion1.04×

Over 4 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend25.9% → 31.3%

Margin has expanded by about 5.4 points — the business is getting more profitable.

Return on equity58.3%

Latest ROE of 58.3% — capital is generating a healthy return.

Growth qualityrev 10% · PAT 17%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $8.5B · EPS 2.31

Est. earnings growth +81.6%

Next fiscal year

Rev $40.7B · EPS 11.57

Est. earnings growth +22.3%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2026)

$23.2B

Net margin

31.3%

ROE

58.3%

Revenue CAGR (3y)

+10.1%

Profit CAGR (3y)

+17.2%

EPS (FY2026)

5.76

Net profit (FY2026)

$7.3B

Ask MarketChacha about LRCX

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Sep 1, 2026
Lam Research shares fell as UBS lowered its price target to $425 from $435 (maintaining Buy) and an SEC filing disclosed a pre-arranged insider sale of 5,000 shares by the chief legal officer, amid broader selling pressure on high-multiple tech names and rising yields.
source 1 ↗source 2 ↗source 3 ↗· confidence: high
Jul 21, 2026
Lam Research shares rose nearly 5% as part of a broad rally in semiconductor equipment and chip stocks (including KLA, Intel, Marvell, and Micron) driven by optimism around AI-driven wafer fab equipment demand; Evercore ISI raised its price target to $355 while reiterating Outperform on July 20.
source 1 ↗source 2 ↗source 3 ↗· confidence: medium

Daily moves with the verified reason behind them. Education only — not investment advice.

On MarketChacha

Posts about LRCX

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2026	$23.2B	$7.3B	5.76	31.3%	58.3%
FY2025	$18.4B	$5.4B	4.15	29.1%	54.3%
FY2024	$14.9B	$3.8B	2.90	25.7%	44.8%
FY2023	$17.4B	$4.5B	3.32	25.9%	54.9%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$5.8B	$1.8B	1.45	31.2%
2025Q4	$5.3B	$1.6B	1.26	29.8%
2025Q3	$5.3B	$1.6B	1.24	29.5%
2025Q1	$4.7B	$1.3B	1.03	28.2%
2024Q4	$4.4B	$1.2B	0.92	27.2%
2024Q3	$4.2B	$1.1B	0.86	26.8%
2024Q1	$3.8B	$965.8M	0.73	25.5%
2023Q4	$3.8B	$954.3M	0.72	25.4%
2023Q3	$3.5B	$887.4M	0.67	25.5%
2023Q1	$3.9B	$814.0M	6.01	21.0%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-K filing
SEC8/7/2026
8-K — Results of operations, Exhibits
SEC7/29/2026material
10-Q filing
SEC4/23/2026
8-K — Results of operations, Exhibits
SEC4/22/2026material
8-K/A — Executive/director change, Exhibits
SEC2/4/2026
8-K — Executive/director change, Exhibits
SEC2/3/2026material
10-Q filing
SEC1/29/2026
8-K — Results of operations, Exhibits
SEC1/28/2026material

2025

8-K — Security holder rights, Executive/director change, Bylaw/charter change, Shareholder vote results, Exhibits
SEC11/6/2025material
10-Q filing
SEC10/24/2025
8-K — Results of operations, Exhibits
SEC10/22/2025material
8-K — Auditor change, Exhibits
SEC9/11/2025material
10-K filing
SEC8/11/2025
8-K — Results of operations, Exhibits
SEC7/30/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.